TLIS
Vanguard Group’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-31,013
| Closed | -$269K | – | 4412 |
|
|
2024
Q2 | $269K | Hold |
31,013
| – | – | ﹤0.01% | 4121 |
|
|
2024
Q1 | $271K | Hold |
31,013
| – | – | ﹤0.01% | 4124 |
|
|
2023
Q4 | $231K | Buy |
31,013
+294
| +1% | +$2.19K | ﹤0.01% | 4199 |
|
|
2023
Q3 | $177K | Sell |
30,719
-435,617
| -93% | -$2.51M | ﹤0.01% | 4274 |
|
|
2023
Q2 | $224K | Sell |
466,336
-5,090
| -1% | -$2.44K | ﹤0.01% | 4296 |
|
|
2023
Q1 | $231K | Sell |
471,426
-22,735
| -5% | -$11.1K | ﹤0.01% | 4300 |
|
|
2022
Q4 | $220K | Sell |
494,161
-10,925
| -2% | -$4.87K | ﹤0.01% | 4294 |
|
|
2022
Q3 | $344K | Sell |
505,086
-48,287
| -9% | -$32.9K | ﹤0.01% | 4312 |
|
|
2022
Q2 | $450K | Sell |
553,373
-59,059
| -10% | -$48K | ﹤0.01% | 4316 |
|
|
2022
Q1 | $864K | Sell |
612,432
-112,701
| -16% | -$159K | ﹤0.01% | 4256 |
|
|
2021
Q4 | $2.91M | Buy |
725,133
+156,376
| +27% | +$627K | ﹤0.01% | 3886 |
|
|
2021
Q3 | $3.56M | Buy |
568,757
+23,851
| +4% | +$149K | ﹤0.01% | 3839 |
|
|
2021
Q2 | $6.01M | Buy |
544,906
+154,887
| +40% | +$1.71M | ﹤0.01% | 3496 |
|
|
2021
Q1 | $5.01M | Buy |
+390,019
| New | +$5.01M | ﹤0.01% | 3533 |
|